Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Bailey

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Diabetes, Obesity & Metabolism|May 2, 2022
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G studyTimothy S Bailey, Jasvinder Gill, Merwyn Jones S, et al.
Diabetes, Obesity & Metabolism|June 25, 2021
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trialTimothy S Bailey, Julie Willard, Leslie J Klaff, et al.
Journal of Diabetes|June 6, 2017
Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategiesGuillermo E Umpierrez, Timothy S Bailey, Danielle Carcia, et al.
Diabetes, Obesity & Metabolism|June 16, 2020
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trialLuigi Meneghini, Lawrence Blonde, Jasvinder Gill, et al.
Journal of Diabetes Science and Technology|April 25, 2022
Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 DiabetesLori M Laffel, Timothy S Bailey, Mark P Christiansen, et al.
Journal of Diabetes Science and Technology|July 14, 2022
Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin DosageKevin B Kaiserman, Mark Christiansen, Sunil Bhavsar, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|December 6, 2021
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life StudyTimothy S Bailey, Pierre Evenou, Jasvinder Gill, et al.
Diabetes Technology & Therapeutics|March 30, 2019
A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION StudyMark P Christiansen, Leslie J Klaff, Timothy S Bailey, et al.
Journal of Diabetes Science and Technology|July 27, 2017
A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance EvaluationMark Christiansen, Carmine Greene, Scott Pardo, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Diabetes, Obesity & Metabolism|May 2, 2022
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G studyTimothy S Bailey, Jasvinder Gill, Merwyn Jones S, et al.
Diabetes, Obesity & Metabolism|June 25, 2021
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trialTimothy S Bailey, Julie Willard, Leslie J Klaff, et al.
Journal of Diabetes|June 6, 2017
Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategiesGuillermo E Umpierrez, Timothy S Bailey, Danielle Carcia, et al.
Diabetes, Obesity & Metabolism|June 16, 2020
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trialLuigi Meneghini, Lawrence Blonde, Jasvinder Gill, et al.
Journal of Diabetes Science and Technology|April 25, 2022
Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 DiabetesLori M Laffel, Timothy S Bailey, Mark P Christiansen, et al.
Journal of Diabetes Science and Technology|July 14, 2022
Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin DosageKevin B Kaiserman, Mark Christiansen, Sunil Bhavsar, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|December 6, 2021
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life StudyTimothy S Bailey, Pierre Evenou, Jasvinder Gill, et al.
Diabetes Technology & Therapeutics|March 30, 2019
A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION StudyMark P Christiansen, Leslie J Klaff, Timothy S Bailey, et al.
Journal of Diabetes Science and Technology|July 27, 2017
A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance EvaluationMark Christiansen, Carmine Greene, Scott Pardo, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Pageof 11